Antibody avidity meets multiple myeloma

Competing interests

S.R.R. is an employee of Gyes (a biotechnology company developing therapeutic antibodies based on avidity-engineered molecules), and is a former employee of Genmab and Lava Therapeutics and owns stock of Genmab and Lava Therapeutics. P.W.H.I.P. is an employee of Gyes and the Leiden University Medical Center and a former employee of Genmab and Lava Therapeutics, owns options and/or stock of Lava Therapeutics and Gyes, and is an inventor on patent applications relating to bispecific and avidity-engineered molecules, including T cell engagers.

留言 (0)

沒有登入
gif